98 related articles for article (PubMed ID: 3277032)
1. Gemfibrozil therapy in patients with coronary heart disease.
Bell H; Dittmeier G; Martinez L
Mo Med; 1988 Jan; 85(1):27-30. PubMed ID: 3277032
[No Abstract] [Full Text] [Related]
2. Gemfibrozil, lipids, and coronary risk.
Rifkind BM
N Engl J Med; 1987 Nov; 317(20):1279-81. PubMed ID: 3313042
[No Abstract] [Full Text] [Related]
3. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.
Frick MH; Elo O; Haapa K; Heinonen OP; Heinsalmi P; Helo P; Huttunen JK; Kaitaniemi P; Koskinen P; Manninen V
N Engl J Med; 1987 Nov; 317(20):1237-45. PubMed ID: 3313041
[TBL] [Abstract][Full Text] [Related]
4. The Gemfibrozil Study.
Manninen V
Acta Med Scand Suppl; 1985; 701():83-8. PubMed ID: 3907298
[TBL] [Abstract][Full Text] [Related]
5. Effect of gemfibrozil on serum lipid levels.
Dahlén G; Gillnäs T; Børresen AL; Berg K; Ericson C
Artery; 1980; 7(3):224-31. PubMed ID: 7008748
[TBL] [Abstract][Full Text] [Related]
6. Gemfibrozil for hyperlipidemia.
Med Lett Drugs Ther; 1982 Jun; 24(612):59-60. PubMed ID: 6953310
[No Abstract] [Full Text] [Related]
7. Effects of gemfibrozil on serum lipids.
Samuel P
Am J Med; 1983 May; 74(5A):23-7. PubMed ID: 6573843
[TBL] [Abstract][Full Text] [Related]
8. Gemfibrozil--a new lipid lowering agent.
Nash DT
J Med; 1980; 11(2-3):107-16. PubMed ID: 6931871
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the effectiveness of gemfibrozil in primary dyslipoproteinemias. I. Changes in lipid levels after treatment (the "net" reduction)].
Sznajd J; Malczewska-Malec M; Idzior-Waluś B; Jamska B; Nowacki G
Przegl Lek; 1987; 44(12):828-36. PubMed ID: 3330252
[No Abstract] [Full Text] [Related]
10. Effects of gemfibrozil on plasma lipoprotein-apolipoprotein distribution and platelet reactivity in patients with hypertriglyceridemia.
Sirtori CR; Franceschini G; Gianfranceschi G; Sirtori M; Montanari G; Tremoli E; Maderna P; Colli S; Zoppi F
J Lab Clin Med; 1987 Sep; 110(3):279-86. PubMed ID: 3475394
[TBL] [Abstract][Full Text] [Related]
11. [Anti-arrhythmic action of penfenon and clofibrate].
Ryzhenkov VE; Miroshkin PM
Patol Fiziol Eksp Ter; 1980; (5):58-61. PubMed ID: 7422376
[No Abstract] [Full Text] [Related]
12. Gemfibrozil and coronary heart disease.
N Engl J Med; 1988 May; 318(19):1274-5. PubMed ID: 3163103
[No Abstract] [Full Text] [Related]
13. Clinical results with gemfibrozil and background to the Helsinki Heart Study.
Manninen V
Am J Cardiol; 1983 Aug; 52(4):35B-38B. PubMed ID: 6351578
[No Abstract] [Full Text] [Related]
14. The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate.
Nye ER; Sutherland WH; Temple Wa
N Z Med J; 1980 Nov; 92(671):345-9. PubMed ID: 6935550
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the effectiveness of gemfibrozil in primary dyslipoproteinemias. II. Relation between the results of treatment and type of dyslipoproteinemia].
Sznajd J; Malczewska-Malec M; Idzior-Waluś B; Iwanejko J; Nowacki G
Przegl Lek; 1987; 44(12):837-43. PubMed ID: 3330253
[No Abstract] [Full Text] [Related]
16. Clinical results with gemfibrozil.
Pickering JE
Am J Cardiol; 1983 Aug; 52(4):39B-40B. PubMed ID: 6351579
[No Abstract] [Full Text] [Related]
17. Lessons from the Helsinki Heart Study. Fibric acid therapy for dyslipidemia.
Grundy SM
Postgrad Med; 1988 Jul; 84(1):217-8, 223-31. PubMed ID: 3164473
[No Abstract] [Full Text] [Related]
18. The hypolipidemic effect of gemfibrozil on hyperlipidemia in patients with non-insulin-dependent diabetes mellitus.
Chang DM; Fuh MM; Jeng CY; Shian LR
Taiwan Yi Xue Hui Za Zhi; 1986 May; 85(5):443-50. PubMed ID: 3463653
[No Abstract] [Full Text] [Related]
19. Normalization of lipoprotein lipase and hepatic lipase by gemfibrozil results in correction of lipoprotein abnormalities in chronic renal failure.
Pasternack A; Vänttinen T; Solakivi T; Kuusi T; Korte T
Clin Nephrol; 1987 Apr; 27(4):163-8. PubMed ID: 3555908
[TBL] [Abstract][Full Text] [Related]
20. The effect of Gemfibrozil on human serum apolipoproteins and on serum reserve cholesterol binding capacity (SRCBC).
Børresen AL; Berg K; Dahlén G; Gillnäs T; Ericson C
Artery; 1981; 9(1):77-86. PubMed ID: 7018466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]